Abstract
‘Fen-phen’ refers to the off-label combination of the appetite suppressants fenfluramine and phentermine. The rationale for the fen-phen combination was that the two drugs exerted independent actions on brain satiety mechanisms so that it was possible to use lower doses of each drug and yet retain a common action on suppressing appetite while minimizing adverse drug effects. The focus of the present review is to consider whether fenfluramine and phentermine exert actions that are additive in nature or whether these two drugs exhibit drug-drug synergism. The fen-phen combination results in synergism for the suppression of appetite and body weight, the reduction of brain serotonin levels, pulmonary vasoconstriction and valve disease. Fen-phen synergism may reflect changes in the pharmacokinetics of drug distribution, common actions on membrane ion currents, or interactions between neuronal release and reuptake mechanisms with MAO-mediated transmitter degradation. The synergism between fenfluramine and phentermine highlights the need to more completely understand the pharmacology and neurochemistry of appetite suppressants prior to use in combination pharmacotherapy for the treatment of obesity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wellman, P., Maher, T. Synergistic interactions between Fenfluramine and Phentermine. Int J Obes 23, 723–732 (1999). https://doi.org/10.1038/sj.ijo.0800920
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0800920
Keywords
This article is cited by
-
Brain–gut–microbiome interactions in obesity and food addiction
Nature Reviews Gastroenterology & Hepatology (2020)
-
GLP-1/glucagon receptor co-agonism for treatment of obesity
Diabetologia (2017)
-
Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat
Psychopharmacology (2015)
-
The floating blueprint of hypothalamic feeding circuits
Nature Reviews Neuroscience (2004)
-
5‐hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension
British Journal of Pharmacology (2000)